Studies have demonstrated that MARCH5 was significantly up-regulated and contributed to the malignant progression in several types of human cancers, including breast cancer [27], nasopharyngeal carcinoma [28]and liver cancer [29]. This evidence concerns the gene MARCHF5 and nasopharyngeal carcinoma.